The scenario approach for countries considering the addition of oral cholera vaccination in cholera preparedness and control plans

The Lancet Infectious Diseases

Volumn 16, Issue 1, 2016, Pages 125-129

  Deen, Jacqueline ^a   von Seidlein, Lorenz ^b   Luquero, Francisco J ^a,c   Troeger, Christopher ^d   Reyburn, Rita ^e   Lopez, Anna Lena ^f   Debes, Amanda ^a   Sack, David A ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c EPICENTRE   (France)

^d UNIVERSITY OF WASHINGTON   (United States)

^e MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^f UNIVERSITY OF THE PHILIPPINES MANILA   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA VACCINE;

CHOLERA; DISEASE BURDEN; EMERGENCY; EPIDEMIC; HEALTH CARE; HUMAN; MASS IMMUNIZATION; NATURAL DISASTER; PRIORITY JOURNAL; REVIEW; SANITATION; VACCINATION; ZIMBABWE; COMMUNICABLE DISEASE CONTROL; HEALTH CARE POLICY; LEGISLATION AND JURISPRUDENCE; ORAL DRUG ADMINISTRATION; ORGANIZATION AND MANAGEMENT; WORLD HEALTH ORGANIZATION;

ADMINISTRATION, ORAL; CHOLERA; CHOLERA VACCINES; COMMUNICABLE DISEASE CONTROL; EMERGENCIES; HEALTH POLICY; HUMANS; WORLD HEALTH ORGANIZATION;

EID: 85027921703     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(15)00298-4     Document Type: Review

References (27)

1. WHO. Cholera, 2013. Wkly Epidemiol Rec 89 (2014), 345–355.
2. Clemens, J, Shin, S, Sur, D, Nair, GB, Holmgren, J, New-generation vaccines against cholera. Nat Rev Gastroenterol Hepatol 8 (2011), 701–710.
3. Yen, C, Hyde, TB, Costa, AJ, et al. The development of global vaccine stockpiles. Lancet Infect Dis 15 (2015), 340–347.
4. Martin, S, Costa, A, Perea, W, Stockpiling oral cholera vaccine. Bull World Health Organ, 90, 2012, 714.
5. Martin, S, Lopez, AL, Bellos, A, et al. Post-licensure deployment of oral cholera vaccines: a systematic review. Bull World Health Organ 92 (2014), 881–893.
6. WHO. Oral cholera vaccines in mass immunization campaigns: guidance for planning and use, 2010, World Health Organization, Geneva.
7. WHO. Guidance on how to access the oral cholera vaccine (OCV) from the ICG emergency stockpile, 2013, World Health Organization, Geneva.
8. WHO. An old enemy returns. Bull World Health Organ 87 (2009), 85–86.
9. Reyburn, R, Deen, JL, Grais, RF, et al. The case for reactive mass oral cholera vaccinations. PLoS Negl Trop Dis, 5, 2011, e952.
10. WHO. Meeting of the Strategic Advisory Group of Experts on immunization, October 2009—conclusions and recommendations. Wkly Epidemiol Rec 84 (2009), 517–532.
11. Date, KA, Vicari, A, Hyde, TB, et al. Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010–2011. Emerg Infect Dis 17 (2011), 2105–2112.
12. Ivers, LC, Teng, JE, Lascher, J, et al. Use of oral cholera vaccine in Haiti: a rural demonstration project. Am J Trop Med Hyg 89 (2013), 617–624.
13. Rouzier, V, Severe, K, Juste, MA, et al. Cholera vaccination in urban Haiti. Am J Trop Med Hyg 89 (2013), 671–681.
14. WHO. Surveillance in Post Extreme Emergencies and Disasters (SPEED). http://www.wpro.who.int/philippines/areas/emergencies_disasters/speed/en/ (accessed Sept 27, 2015).
15. Legros, D, Paquet, C, Perea, W, et al. Mass vaccination with a two-dose oral cholera vaccine in a refugee camp. Bull World Health Organ 77 (1999), 837–842.
16. Dorlencourt, F, Legros, D, Paquet, C, Neira, M, Ivanoff, B, Le Saout, E, Effectiveness of mass vaccination with WC/rBS cholera vaccine during an epidemic in Adjumani district, Uganda. Bull World Health Organ 77 (1999), 949–950.
17. WHO. Cholera prevention measures reduce transmission among displaced people in South Sudan. http://who.int/features/2015/cholera-south-sudan/en/ (accessed Sept 27, 2015).
18. Deen, JL, von Seidlein, L, Sur, D, et al. The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa. PLoS Negl Trop Dis, 2, 2008, e173.
19. Agtini, MD, Soeharno, R, Lesmana, M, et al. The burden of diarrhoea, shigellosis, and cholera in North Jakarta, Indonesia: findings from 24 months surveillance. BMC Infect Dis, 5, 2005, 89.
20. Lucas, ME, Deen, JL, von Seidlein, L, et al. Effectiveness of mass oral cholera vaccination in Beira, Mozambique. N Engl J Med 352 (2005), 757–767.
21. Khatib, AM, Ali, M, von Seidlein, L, et al. Effectiveness of an oral cholera vaccine in Zanzibar: findings from a mass vaccination campaign and observational cohort study. Lancet Infect Dis 12 (2012), 837–844.
22. Ciglenecki, I, Sakoba, K, Luquero, FJ, et al. Feasibility of mass vaccination campaign with oral cholera vaccines in response to an outbreak in Guinea. PLoS Med, 10, 2013, e1001512.
23. Luquero, FJ, Grout, L, Ciglenecki, I, et al. Use of Vibrio cholerae vaccine in an outbreak in Guinea. N Engl J Med 370 (2014), 2111–2120.
24. Troeger, C, Sack, D, Chao, DL, Evaluation of targeted mass cholera vaccination strategies in Bangladesh: a demonstration of a new cost-effectiveness calculator. Am J Trop Med Hyg 91 (2014), 1181–1189.
25. Ali, M, Lopez, AL, You, YA, et al. The global burden of cholera. Bull World Health Organ, 90, 2012, 209 18A.
26. Hendriksen, RS, Price, LB, Schupp, JM, et al. Population genetics of Vibrio cholerae from Nepal in 2010: evidence on the origin of the Haitian outbreak. MBio 2 (2011), e00157–e00211.
27. WHO. Oral cholera vaccine stockpile for cholera emergency response, 2013, World Health Organization, Geneva.